[This Week's IPO] July Third Week Demand Forecast and Subscription Schedule

[Asia Economy Reporter Jang Hyowon] In the third week of this month (July), Krafton, Maxst, Everybot, and Emro will conduct demand forecasting for institutional investors. Curacle is preparing for a general public subscription.

◆Krafton= Krafton, the maker of the online game ‘Battlegrounds,’ will conduct demand forecasting for institutional investors from the 14th to the 27th to list on the KOSPI market. Battlegrounds has sold over 75 million copies (including PC and console), and ‘Battlegrounds Mobile’ has surpassed 1 billion cumulative downloads globally except for China, being recognized as a powerful global IP.

Krafton's desired public offering price range is 400,000 to 498,000 KRW, with a market capitalization after listing estimated between 19.5592 trillion and 24.3512 trillion KRW. After the Financial Supervisory Service requested a revised report, the desired public offering price was lowered by about 10% from 458,000?557,000 KRW.

The public offering volume is 8,654,230 shares, consisting of 5,624,000 new shares (65%) and 3,032,030 existing shares (35%). The lead underwriter is Mirae Asset Securities, with Credit Suisse, NH Investment & Securities, Citi Global Markets Securities, and JP Morgan as joint underwriters.

◆Maxst= Founded in 2010, Maxst is a company that has independently developed augmented reality (AR) core technology and led its localization. Currently, over 6,900 AR-related apps developed using Maxst’s AR development platform ‘MAXST AR SDK (Software Development Kit)’ have been released by more than 12,000 developers in 50 countries.

Maxst is conducting AR solution business in various industrial fields with leading domestic companies such as Hyundai Motor, Samsung Electronics, and Daewoo Shipbuilding & Marine Engineering. Since last year, it has launched ‘MAXWORK,’ an AR solution for small and medium-sized enterprises, focusing on smart factory manufacturing innovation projects.

The desired public offering price band is 11,000 to 13,000 KRW, aiming to raise 11 billion to 13 billion KRW. All 1 million shares offered are newly issued. Demand forecasting will be held on July 12?13, followed by public subscription from the 16th to the 19th. Hana Financial Investment is the lead underwriter.

◆Everybot= Demand forecasting, originally planned for last month, will be conducted on the 13th and 14th. The desired public offering price is 32,600 to 36,700 KRW, with a total public offering amount of approximately 36.5 billion KRW. The lead underwriter is NH Investment & Securities.

Founded in 2015, Everybot developed a robot vacuum cleaner dedicated to wet mopping. Last year, leveraging price competitiveness and technological capabilities, it achieved sales of 49.2 billion KRW and operating profit of 13 billion KRW.

Robot vacuum cleaners hold a dominant market share in the household service robot market. As the number of dual-income households, single-person households, and pet owners increases, the robot vacuum cleaner market is expected to be positively influenced.

◆Emro= Established in 2000, Emro is a supply chain management (SCM) software solution company. Emro maintains its market-leading position by supplying over 1,000 purchasing SCM solutions to more than 280 companies across various industries including automotive, electronics, steel, chemical, distribution, medical, and finance.

Notably, many global conglomerates such as Samsung, Hyundai Motor, LG, SK, POSCO, Amorepacific, as well as representative public enterprises like Korea Electric Power Corporation, Incheon International Airport Corporation, and Health Insurance Review & Assessment Service use Emro’s solutions.

Emro’s total public offering shares are 1,016,104, with a desired price band of 20,100 to 22,600 KRW per share, amounting to approximately 20.4 billion KRW at the lower end. Demand forecasting will be conducted over two days on the 15th and 16th to finalize the offering price, followed by general public subscription on the 21st and 22nd. The listing is scheduled for the end of next month. The lead underwriter is Korea Investment & Securities.

◆Curacle= Curacle, a company specializing in vascular diseases, possesses a drug development platform technology for vascular endothelial cells called ‘SOLVADYS.’ This technology is a platform that comprehensively performs mechanism and efficacy verification through effective disease phenotype screening that inhibits vascular endothelial dysfunction based on human endothelial cells.

Curacle’s total public offering shares are 2,133,333. The desired public offering price band is 20,000 to 25,000 KRW. Demand forecasting for institutional investors was conducted over two days on the 7th and 8th, and general subscription will be held on the 13th and 14th. The listing is scheduled for July. The lead underwriter is Samsung Securities.

This content was produced with the assistance of AI translation services.